BDBM703859 US20240368151, Compound 3

SMILES CCCN1C[C@H](C(=O)N[C@H](C)CC)C=C2c3cccc4[nH]cc(c34)C[C@H]21

InChI Key InChIKey=AGTKNXCESPGYJK-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 703859   

Target5-hydroxytryptamine receptor 2A(Human)
Gilgamesh Pharmaceuticals

US Patent
LigandPNGBDBM703859(US20240368151, Compound 3)
Affinity DataKi:  1.36nMAssay Description:The binding affinities of disclosed compounds at the ketanserin binding site of the 5-HT2A receptor and the LSD binding site of the 5-HT2B receptor w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2B(Human)
Gilgamesh Pharmaceuticals

US Patent
LigandPNGBDBM703859(US20240368151, Compound 3)
Affinity DataKi:  4.09nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent